Urgent.News

One page, thousands of outlets. See who else covered it.

Editions

Finance & Markets

Moderna stock surges as melanoma vaccine trial shows "landmark moment"

Moderna and Merck announced study results that reflect a "landmark moment" in treatment for one of the deadliest forms of skin cancer.

We haven't written up this one. CBS News has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at cbsnews.com →

More in Finance & Markets

More from Wednesday 19 August →